Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruijgrok

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivoCasper de Boer, Zachary Armstrong, Vincent A J Lit, et al.
Journal of the American Geriatrics Society|July 30, 2008
Lack of effectiveness of a multidisciplinary fall-prevention program in elderly people at risk: a randomized, controlled trialMarike R C Hendriks, Michel H C Bleijlevens, Jolanda C M van Haastregt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 16, 2024
Conformational and Electronic Variations in 1,2- and 1,5a-Cyclophellitols and their Impact on Retaining α-Glucosidase InhibitionTim P Ofman, Jurriaan J A Heming, Alba Nin-Hill, et al.
Journal of the American Chemical Society|February 25, 2025
Bespoke Activity-Based Probes Reveal that the <i>Pseudomonas aeruginosa</i> Endoglycosidase, PslG, Is an Endo-β-glucanaseGijs Ruijgrok, Wendy A Offen, Isabelle B Pickles, et al.
ACS Central Science|September 2, 2024
<i>Epi</i>-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other CoronavirusesMelissa Thaler, Tim P Ofman, Ken Kok, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivoCasper de Boer, Zachary Armstrong, Vincent A J Lit, et al.
Journal of the American Geriatrics Society|July 30, 2008
Lack of effectiveness of a multidisciplinary fall-prevention program in elderly people at risk: a randomized, controlled trialMarike R C Hendriks, Michel H C Bleijlevens, Jolanda C M van Haastregt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 16, 2024
Conformational and Electronic Variations in 1,2- and 1,5a-Cyclophellitols and their Impact on Retaining α-Glucosidase InhibitionTim P Ofman, Jurriaan J A Heming, Alba Nin-Hill, et al.
Journal of the American Chemical Society|February 25, 2025
Bespoke Activity-Based Probes Reveal that the <i>Pseudomonas aeruginosa</i> Endoglycosidase, PslG, Is an Endo-β-glucanaseGijs Ruijgrok, Wendy A Offen, Isabelle B Pickles, et al.
ACS Central Science|September 2, 2024
<i>Epi</i>-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other CoronavirusesMelissa Thaler, Tim P Ofman, Ken Kok, et al.
Pageof 9